Cardiovascular Morbidity Clinical Trial
Official title:
Experimental Exposure to Air Pollutants and Sympathetic Nerve Activity in Human Subjects
The primary hypothesis of the study is that in healthy elderly subjects experimental exposure to air pollutants increases sympathetic nervous system activity compared with sham (clean air) exposure. The secondary hypothesis of the study is that combined experimental exposure to air pollutants (particles + ozone) increases sympathetic nervous system activity to a greater extent than does the exposure to particles alone.
In a randomized, double-blind, and cross-over fashion, the participants will be exposed to clean air, ultrafine particles, or ultrafine particles and ozone in an exposure chamber. The investigators will determine blood pressure, heart rate, respiration as well as cardiac output and directly record sympathetic vasomotor tone using the microneurography technique. To elucidate the underlying mechanisms through which particles and ozone affect the autonomic nervous system, the investigators will assess the local and systemic inflammatory response as well as the changes in neurotrophic factors in sputum and blood. In addition, the activation of inflammatory cells in sputum and blood will be analyzed at different points in time after exposures. Changes in sympathetic activity will be correlated with the degree of airway inflammation and oxidative stress assessed in induced sputum and blood. This study will provide important insight in the mechanisms through which air pollution, particularly ultrafine particle exposure, increases cardiovascular risk in human subjects and generate a human model for mechanistic and therapeutic studies. ;
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04900610 -
The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis
|
N/A | |
Completed |
NCT02359370 -
The Effects of Lidocaine and Magnesium Sulphate on the Attenuation of the Hemodynamic Response to Tracheal Intubation
|
Phase 4 | |
Not yet recruiting |
NCT05435898 -
Assessment and Digital-health Based Intervention on Subclinical Organ Damage and Cardiovascular Risk in Chinese
|
||
Recruiting |
NCT04624503 -
Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19
|
||
Recruiting |
NCT04428827 -
Outcome of Patients With Primary Aldosteronism
|
||
Completed |
NCT04609332 -
Endothelial Damage and Angiogenesis Biomarkers During COVID-19
|
||
Completed |
NCT04132531 -
Effect of Weight Loss Surgery on Stem Cells.
|
||
Completed |
NCT05057650 -
Help Everyone Assess Risk Today: LEnten Nutrition Study (HEART-LENS)
|
N/A | |
Recruiting |
NCT05432856 -
Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women
|
N/A | |
Completed |
NCT04189497 -
Development of a Prognostic Tool for the Stratification of Cardiovascular Risk in Patients With Ischemic Stroke
|
||
Not yet recruiting |
NCT05802121 -
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
|
Early Phase 1 | |
Recruiting |
NCT05645978 -
Association of Obesity and Cardiovascular Outcomes in Patients With Pacemaker
|
||
Recruiting |
NCT05645952 -
Association of Obesity and Cardiovascular Outcomes in Dilated Cardiomyopathy
|
||
Recruiting |
NCT05645965 -
Association of Obesity and Cardiovascular Outcomes in Patients With Implantable Cardioverter-defibrillator (ICD)
|
||
Recruiting |
NCT05645939 -
Association of Obesity and Cardiovascular Outcomes in Hypertrophic Cardiomyopathy
|
||
Completed |
NCT05293379 -
Prospective, Multicenter Study Assessing a Screening Campaign for Cardiovascular Diseases Risk Factors During SARS-CoV-2 Epidemic
|
||
Completed |
NCT03256175 -
The Effect of Peri-percutaneous Coronary Intervention Oxygenation on Myocardial Protection & Cardiovascular Fitness
|
N/A | |
Enrolling by invitation |
NCT03451929 -
Kidney Function and Cardiovascular Events: Cohort Study in General Population
|
N/A | |
Completed |
NCT04717986 -
Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)
|
N/A | |
Not yet recruiting |
NCT06103448 -
Prediction of the Risks of Cardiovascular Mortality
|